Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia

Livio Pagano, Gina Zini, Maria Teresa Voso, Alfonso Piciocchi, Luana Fianchi, Giovanna Rosaria Mansueto, Marianna Criscuolo, Pasquale Niscola, Luca Maurillo, Pellegrino Musto, Giovanna Mansueto, Maria Antonietta Aloe-Spiriti, Francesco Buccisano, Adriano Venditti, Andrea Tendas, Anna Lina Piccioni, Roberto Latagliata, Nunzio Filardi, Alberto Fragasso, Susanna FenuMassimo Breccia

Risultato della ricerca: Contributo in rivistaArticolo in rivista

23 Citazioni (Scopus)

Fingerprint

Entra nei temi di ricerca di 'Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia'. Insieme formano una fingerprint unica.

Medicine & Life Sciences